ShuYu Civilian Pharmacy Management
Management criteria checks 4/4
ShuYu Civilian Pharmacy's CEO is Guangxia Qin, appointed in Nov 2015, has a tenure of 9.17 years. directly owns 18.25% of the company’s shares, worth CN¥813.72M. The average tenure of the management team and the board of directors is 5.2 years and 3.1 years respectively.
Key information
Guangxia Qin
Chief executive officer
CN¥1.0m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 9.2yrs |
CEO ownership | 18.3% |
Management average tenure | 5.2yrs |
Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Market Cool On ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) Revenues Pushing Shares 27% Lower
Jan 12Returns On Capital Signal Tricky Times Ahead For ShuYu Civilian Pharmacy (SZSE:301017)
Dec 19Even With A 32% Surge, Cautious Investors Are Not Rewarding ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) Performance Completely
Nov 09ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt
Oct 03A Piece Of The Puzzle Missing From ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 25% Share Price Climb
Sep 06ShuYu Civilian Pharmacy (SZSE:301017) Could Be Struggling To Allocate Capital
Jul 25ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Shares May Have Slumped 32% But Getting In Cheap Is Still Unlikely
Jun 21ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky
Jun 20These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively
Mar 04CEO
Guangxia Qin (53 yo)
9.2yrs
Tenure
CN¥1,028,400
Compensation
Ms. Guangxia Qin is President & Director of ShuYu Civilian Pharmacy Corp. Ltd. from November 2015.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 9.2yrs | CN¥1.03m | 18.25% CN¥ 813.7m | |
Financial Director | 5.2yrs | CN¥420.10k | no data | |
VP & Director | 2.6yrs | CN¥701.20k | no data | |
VP & Director | 2.6yrs | CN¥671.20k | no data | |
VP, Board Secretary & Director | 9.1yrs | CN¥1.26m | no data | |
Accounting Supervisor | no data | no data | no data |
5.2yrs
Average Tenure
52yo
Average Age
Experienced Management: 301017's management team is seasoned and experienced (5.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 9.2yrs | CN¥1.03m | 18.25% CN¥ 813.7m | |
VP & Director | 3.1yrs | CN¥701.20k | no data | |
VP & Director | 2.4yrs | CN¥671.20k | no data | |
VP, Board Secretary & Director | 9.2yrs | CN¥1.26m | no data | |
Chairman of the Board | 9.2yrs | CN¥901.00k | 35.43% CN¥ 1.6b | |
Independent Director | 3.1yrs | CN¥60.00k | no data | |
Chairman of Supervisory Board | 3.1yrs | no data | no data | |
Non-Independent Director | 3.1yrs | no data | no data | |
Independent Director | 3.1yrs | CN¥60.00k | no data | |
Independent Director | 6yrs | CN¥60.00k | no data | |
Employee Representative Supervisor | 9.2yrs | no data | no data | |
Independent Director | less than a year | no data | no data |
3.1yrs
Average Tenure
52yo
Average Age
Experienced Board: 301017's board of directors are considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/12 06:01 |
End of Day Share Price | 2025/01/10 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ShuYu Civilian Pharmacy Corp., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jiaxi Xu | Industrial Securities Co. Ltd. |